MOBE® recently announced an extension of its program for weight management to meet the growing demand from employers and health benefits leaders for effective, sustainable solutions in obesity management. As GLP-1s and other anti-obesity medications (AOMs) become more common, MOBE’s enhanced program addresses the challenges that come with weight loss medications—such as high costs, adherence issues, and health risks—by delivering whole-person, comprehensive guided care.
“We understand that effective weight management is about more than medication alone. It’s about helping individuals make lasting changes that support both physical and emotional health,” said Kurt Cegielski, Chief Commercial Officer at MOBE. “Our comprehensive approach to weight management has delivered measurable outcomes for over a decade, and this extension allows us to support more people on their journey.”
With the rising popularity of GLP-1s, employers face complex challenges. MOBE’s program is unique in its purposeful decision not to prescribe new medications. This approach helps reduce the increased likelihood of medication errors and the potential negative impact on the safe management of other conditions, particularly for individuals with complex health profiles.
Each participant is paired with a dedicated MOBE Guide—a personalized health partner who assists in setting achievable weight goals and making sustainable changes in diet, physical activity, mindset, and overall wellness. And, for those currently taking or interested in exploring AOM options, a MOBE Pharmacist ensures each participant understands how to use AOMs effectively—without creating new health risks.
While effective, GLP-1s and AOMs carry substantial cost implications. MOBE addresses these by helping participants and providers explore lower-cost options and avoiding repeated interventions due to medication switching or restarts. By considering all aspects of a participant’s health, MOBE helps employers lower costs tied to frequent weight re-gain and uncoordinated medication use.
“By coordinating with prescribers, we ensure safe, effective medication management,” said Leslie Helou, PharmD, SVP, Health Outcomes Strategy at MOBE.
The MOBE weight management program extension is open to individuals with a BMI over 25 and who have weight loss goals, particularly benefiting those with conditions like type 2 diabetes, hypertension, and cardiovascular disease.
MOBE’s philosophy centers on understanding people, not just their numbers. With this program extension, MOBE reinforces its commitment to delivering meaningful, sustainable health outcomes by providing comprehensive support that goes beyond medications.
For more information about MOBE’s new program extension, visit https://www.mobeforlife.com/weight-management